Showing 1 - 12 results of 12 for search 'N. A. Totolyan', query time: 0.68s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
CLIPPERS. Three clinical cases and review by L. N. Prakhova, A. S. Parfyonova, Zh. I. Savintseva, A. G. Ilves, E. V. Bubnova, V. S. Krasnov, A. M. Tarasova, N. A. Totolyan
Published 2020-01-01
Article -
8
Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy by V. S. Krasnov, K. Z. Bakhtiyarova, E. P. Evdoshenko, D. S. Korobko, T. O. Simaniv, N. A. Totolyan, N. V. Khachanova, M. V. Shumilina, M. V. Davydovskaya
Published 2022-12-01
Article -
9
-
10
Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis by K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Published 2020-06-01
Article -
11
Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets by N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Published 2020-10-01
Article -
12
Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders by A. N. Boyko, K. Z. Bakhtiyarova, L. V. Brylev, M. N. Zakharova, D. S. Kasatkin, D. S. Korobko, S. V. Kotov, V. S. Krasnov, N. A. Malkova, E. V. Popova, S. A. Sivertseva, T. O. Simaniv, A. A. Sokolova, N. A. Totolyan, T. N. Trushnikova, F. A. Khabirov, N. V. Khachanova
Published 2021-10-01
Article